Andre Henri Goy, MD
Lymphoma, Hematology Oncology
Accepting new patients
Dr. Goy leads the John Theurer Cancer Center, New Jersey’s largest cancer care program. A specialist in lymphoma care, he also directs the state's largest lymphoma treatment and research program. Widely known for his work in mantle cell lymphoma, he was the lead investigator in the development of three FDA-approved drugs for this disease: bortezomib, lenalidomide, and ibrutinib. He is now assessing biomarkers for lymphoma as well as novel anticancer agents, drug combinations, and non-chemotherapy options.
Titles
Physician in Chief Hackensack Meridian Health Oncology Care Transformation Services
Chairman & Chief Physcian Officer, John Theurer Cancer Center at Hackensack University Medical Center
Lymphoma Division Chief, John Theurer Cancer Center
Scientific Research Articles
Publications
- Giants General Manager Gives Back
- Cancer Free After Clinical Trial
- Partners in Cancer Care
- Lymphoma: Top 5 Questions and Answers You Need to Know
- Cancer and Obesity: What’s the Connection?
- 8 Common Cancers in Young Adults
- 5 Impressive Benefits of a Plant-Based Diet
- Racing Back to Life: One Woman’s Journey After Cancer
Provider Information
Specialties
Lymphoma
Hematology Oncology
Languages
English
French
Age groups seen
Adults
Adults Over 65
Hospital affiliations
Hackensack University Medical Center
JFK University Medical Center
Palisades Medical Center
Education
Fellowship, Memorial Sloan-Kettering Cancer Center
Hematology & Oncology, 1997
Fellowship, Memorial Sloan-Kettering Cancer Center
Hematology & Oncology, 1995
Residency, Centre Hospitalier Universitaire de Grenoble
Internal Medicine, 1983
Universite Joseph Fourier, Medical School
MD, 1988
